English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

WHO currently recommends molecular testing for all patients who are included in the suspect category. The molecular examination requires facilities with biosafety level 2 (BSL-2), meanwhile for culture testing at least BSL-3. Viral culture is not recommended for routine diagnosis. The recommended method for virus detection is nucleic acid amplification by real-time reverse-transcription polymerase chain reaction (rRTPCR) and by sequencing. The sample is said to be positive (confirm SARS-CoV-2) if the RRT-PCR is positive for at least two genomic targets (N, E, S, or RdRP) that are SARSCoV-2 specific; OR positive RRT-PCR for betacoronavirus, supported by sequencing results of part or all of the viral genome according to SARS-CoV-2. To reduce the spread of the virus, the government began to carry out massive swab tests. Molecular rapid tests are easier to perform and faster because the process is automated which greatly helps speed up detection. To support a safe swab process, in this study an integrated portable swab booth was built. The output of this research is expected to contribute to the prevention of the spread of disease caused by the 2019-nCoV virus.

Development of integrated swab chamber for drive thru Covid19 test system